Jonathan D. Cicci

Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype–Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Craig R. Lee, Vindhya Sriramoju, Alexandra Cervantes et al. · Circulation Genomic and Precision Medicine · 2018 · 80 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting

Jesse Martin, Alexis K. Williams, Melissa D. Klein et al. · Genetics in Medicine · 2019 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Denosumab for the Management of Hypercalcemia of Malignancy in Patients With Multiple Myeloma and Renal Dysfunction

Jonathan D. Cicci, Larry W. Buie, Jill Bates et al. · Clinical Lymphoma Myeloma & Leukemia · 2014 · 49 citations

Medicine, Nephrology, Oncology +13

Implementation and Evaluation of a <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy Algorithm in High-Risk Coronary Artery Disease Patients

John Andrew Lee, Craig R. Lee, Brent N. Reed et al. · Pharmacogenomics · 2015 · 37 citations

Medicine, Cardiology, Pharmacology +17

Continuous Care Provided Through Comprehensive Medication Management in an Acute Care Practice Model

T. David Marr, Nicole R. Pinelli, Jamie A. Jarmul et al. · Annals of Pharmacotherapy · 2017 · 25 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +13